Theseus Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Interest and Dividend Income	642,590	611,636	483,066	355,486	272,772	233,034	Upgrade
Total Interest Expense	260,046	247,708	187,247	125,599	97,537	94,140	Upgrade
Net Interest Income	382,544	363,928	295,819	229,887	175,235	138,894	Upgrade
Commissions and Fees	62,426	59,828	52,672	43,556	30,673	24,524	Upgrade
Gain (Loss) on Sale of Loans & Receivables	5,998	5,520	133.3	231.7	-	-	Upgrade
Gain (Loss) on Sale of Investments	925.1	925.1	-6.2	-	-	843	Upgrade
Other Revenue	19,304	19,079	13,960	14,909	13,036	8,382	Upgrade
Revenue Before Loan Losses	471,197	449,281	362,578	288,584	218,944	172,643	Upgrade
Provision for Loan Losses	83,441	79,086	45,487	31,897	48,034	59,425	Upgrade
Revenue	387,756	370,195	317,091	256,687	170,910	113,218	Upgrade
Revenue Growth (YoY)	17.36%	16.75%	23.53%	50.19%	50.96%	-12.79%	Upgrade
Salaries & Employee Benefits	78,361	75,083	63,960	51,002	35,924	24,987	Upgrade
Cost of Services Provided	32,931	30,798	22,876	18,915	17,621	14,474	Upgrade
Other Operating Expenses	35,383	34,790	30,278	26,655	18,480	10,561	Upgrade
Total Operating Expenses	156,002	149,481	123,947	101,425	75,872	53,275	Upgrade
Operating Income	231,754	220,714	193,145	155,262	95,038	59,943	Upgrade
Earnings From Equity Investments	160.3	178.1	76.4	16.7	-	-	Upgrade
EBT Excluding Unusual Items	232,174	221,151	193,221	155,279	95,038	59,991	Upgrade
Pretax Income	231,819	220,796	193,096	155,279	95,038	59,923	Upgrade
Income Tax Expense	55,491	53,002	48,584	40,202	24,756	15,724	Upgrade
Earnings From Continuing Ops.	176,328	167,795	144,512	115,077	70,282	44,198	Upgrade
Minority Interest in Earnings	-2,073	-1,417	-	-	-	-	Upgrade
Net Income	174,255	166,378	144,512	115,077	70,282	44,198	Upgrade
Net Income to Common	174,255	166,378	144,512	115,077	70,282	44,198	Upgrade
Net Income Growth	16.74%	15.13%	25.58%	63.73%	59.02%	-16.03%	Upgrade
Shares Outstanding (Basic)	6,193	6,186	6,100	6,040	6,026	6,007	Upgrade
Shares Outstanding (Diluted)	6,210	6,203	6,124	6,070	6,070	6,055	Upgrade
Shares Change (YoY)	0.88%	1.30%	0.88%	0.01%	0.24%	2.46%	Upgrade
EPS (Basic)	28.14	26.89	23.69	19.05	11.66	7.36	Upgrade
EPS (Diluted)	28.06	26.82	23.60	18.96	11.58	7.30	Upgrade
EPS Growth	15.73%	13.65%	24.48%	63.72%	58.62%	-18.04%	Upgrade
Free Cash Flow	-	-687,385	-704,469	-425,977	-374,655	-9,460	Upgrade
Free Cash Flow Per Share	-	-110.81	-115.04	-70.17	-61.73	-1.56	Upgrade
Dividend Per Share	4.400	4.400	3.600	3.000	2.000	1.000	Upgrade
Dividend Growth	22.22%	22.22%	20.00%	50.00%	100.00%	-	Upgrade
Operating Margin	59.77%	59.62%	60.91%	60.49%	55.61%	52.95%	Upgrade
Profit Margin	44.94%	44.94%	45.57%	44.83%	41.12%	39.04%	Upgrade
Free Cash Flow Margin	-	-185.68%	-222.17%	-165.95%	-219.21%	-8.36%	Upgrade
Effective Tax Rate	23.94%	24.01%	25.16%	25.89%	26.05%	26.24%	Upgrade
Revenue as Reported	731,502	697,248	549,825	414,183	316,481	266,831	Upgrade

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.